| |
SOLAGRAN LIMITED Company Summary |
|
 Solagran is a biotechnology company with a portfolio of higly effective, low side effect, natural pharmaceuticals that it obtains from gree tree foliage. Its patented technology enables the extraction of the live elements of trees in a way that both preserves and amplifies their biological activity. |
|
|
|
 |
Headquarters |
Level 11, 492 St Kilda Road |
 |
| |
|
Melbourne, Victoria, 3004 |
|
| |
|
Australia |
|
|
Telephone |
+61 3 9820 2699 |
|
|
Fax |
+61 3 9820 3155 |
|
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Biotechnology |
|
|
Listed |
1983/12/22 |
|
|
Homepage |
www.solagran.com |
|
| |
|
|
|
|
| |
NEWS |
 |
|
|  Solagran Limited (ASX:SLA) Update on Ropren Production and Marketing In Russia (APR 22, 2008) | | Solagran (ASX:SLA) Announce Marketing Strategy Details For Ropren In Russia (APR 2, 2008) | | Solagran Opens Commercial Scale Plant for Pharmaceutical Grade Polyprenols (MAR 27, 2008) | | Solagran Limited (ASX:SLA) Announce Formal Opening Of Russian Facility (MAR 27, 2008) | | Solagran Limited (ASX:SLA) Announce Approval Of ROPREN for Sale In Russia (MAR 19, 2008) | | Solagran Limited (ASX:SLA) Receives Manufacturing Licence For Ropren (FEB 28, 2008) | | Solagran Limited (ASX:SLA) Announce Key Milestone Passed in Manufacturing Licensing Approval For Ropren (FEB 20, 2008) | | Solagran Limited (ASX:SLA) Announce Unexpected Efficacy of Ropren in Treating Severe Alcoholism (FEB 14, 2008) | | Solagran Limited (ASX: SLA) Announce Proposed Strategic Alliance with Menarini Group (JAN 31, 2008) | | Solagran Limited (ASX:SLA) Ropren Licencing, Marketing and Distribution Announcement (JAN 23, 2008) | | Solagran Limited (ASX:SLA) Announce ADR (American Depository Receipt) Program (JAN 17, 2008) | | Solagran Limited (ASX:SLA) Announce Russian Authorities Accept H.pylori Patent Application (JAN 10, 2008) | | Solagran Ltd (ASX:SLA) Granted Patents for Treatment of Alzheimers and Alcoholism (JAN 8, 2008) | | Solagran Limited (ASX:SLA) on Track for Commercial Production of Ropren in January 2008 (DEC 21, 2007) | | Solagran Limited (ASX: SLA) Expanding BioEffective R Production Facilities in Tomsk (DEC 20, 2007) | | Solagran Limited (ASX: SLA) Notify Re-schedule of Annual General Meeting (NOV 21, 2007) | | Solagran Limited's Bioeffectives to be Used to Treat Alzheimer's Patients and Alcoholics in Russia (NOV 19, 2007) |
|
|
|
|
